Evidence map›Paper›PMID 34840594›Full record

ArticleComputational and mathematical methods in medicine2021

Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.

Xiaolong Tang, Yandong Miao, Jiangtao Wang, Teng Cai, Lixia Yang, Denghai Mi

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xiaolong TangThe First Clinical Medical College, Lanzhou University, Lanzhou City, Gansu Province, China.
Yandong MiaoThe First Clinical Medical College, Lanzhou University, Lanzhou City, Gansu Province, China.
Jiangtao WangThe First Clinical Medical College, Lanzhou University, Lanzhou City, Gansu Province, China.
Teng CaiThe First Clinical Medical College, Lanzhou University, Lanzhou City, Gansu Province, China.
Lixia YangGansu Academy of Traditional Chinese Medicine, Lanzhou City, Gansu Province, China.
Denghai MiThe First Clinical Medical College, Lanzhou University, Lanzhou City, Gansu Province, China.ORCID https://orcid.org/0000-0002-8643-4496
Lanzhou University · CNGansu University of Traditional Chinese Medicine · CNAffiliated Hospital of North Sichuan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccumulating evidence proves that long noncoding RNA (lncRNA) plays a crucial role in maintaining genomic instability. However, it is significantly absent from exploring genomic instability-associated lncRNAs and discovering their clinical significance.

objectiveTo identify crucial mutator-derived lncRNAs and construct a predictive model for prognosis and genomic instability in hepatocellular carcinoma.

methodsFirst, we constructed a mutator hypothesis-derived calculative framework through uniting the lncRNA expression level and somatic mutation number to screen for genomic instability-associated lncRNA in hepatocellular carcinoma. We then selected mutator-derived lncRNA from the genome instability-associated lncRNA by univariate Cox analysis and Lasso regression analysis. Next, we created a prognosis model with the mutator-derived lncRNA signature. Furthermore, we verified the vital role of the model in the prognosis and genomic instability of hepatocellular carcinoma patients. Finally, we examined the potential relationship between the model and the mutation status of TP53.

resultsIn this study, we screened 88 genome instability-associated lncRNAs and built a prognosis model with four mutator-derived lncRNAs. Moreover, the model was an independent predictor of prognosis and an accurate indicator of genomic instability in hepatocellular carcinoma. Finally, the model could catch the TP53 mutation status, and the model was a more effective indicator than the mutation status of TP53 for hepatocellular carcinoma patients.

conclusionThis research adopted a reliable method to analyze the role of lncRNA in genomic instability. Besides, the prognostic model with four mutator-derived lncRNAs is an excellent new indicator of prognosis and genomic instability in hepatocellular carcinoma. In addition, this finding may help clinicians develop therapeutic systems.

Indexed as

Genomic InstabilityBiomarkers, TumorCarcinoma, HepatocellularCarrier ProteinsComputational BiologyFemaleGenes, p53HumansLiver NeoplasmsMaleModels, GeneticMutationNomogramsNuclear ProteinsPrognosisProportional Hazards ModelsBiomarkers, TumorCarrier ProteinsNuclear ProteinsRNA, Long NoncodingUBQLN4 protein, human

Identifiers

PMID34840594
PMCPMC8613502
OpenAlexW3213640090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.